These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4020649)

  • 1. Evaluation of lincomycin as a cholesterol gallstone dissolution rate accelerator.
    Rush BD; Ruwart MJ; Anderson BD; Higuchi WI
    J Pharm Sci; 1985 Jun; 74(6):621-4. PubMed ID: 4020649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro dissolution of cholesterol gallstones. A study of factors influencing rate and a comparison of solvents.
    Allen MJ; Borody TJ; Thistle JL
    Gastroenterology; 1985 Nov; 89(5):1097-103. PubMed ID: 4043667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution rates of model gallstones in human and animal biles and importance of interfacial resistance.
    Molokhia AM; Hofmann AF; Higuchi WI; Tuchinda M; Feld K; Prakongpan S; Danzinger RG
    J Pharm Sci; 1977 Aug; 66(8):1101-5. PubMed ID: 408477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallstone formation and dissolution.
    Coyne MJ; Schoenfield LJ
    Prog Liver Dis; 1976; 5():622-35. PubMed ID: 775559
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms.
    Salvioli G; Igimi H; Carey MC
    J Lipid Res; 1983 Jun; 24(6):701-20. PubMed ID: 6886562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution kinetics of cholesterol in simulated bile II: influence of simulated bile composition.
    Kwan KH; Higuchi WI; Hofmann AF
    J Pharm Sci; 1978 Dec; 67(12):1711-4. PubMed ID: 722485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 8. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
    Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
    Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.
    Nilsell K; Angelin B; Liljeqvist L; Einarsson K
    Gastroenterology; 1985 Aug; 89(2):287-93. PubMed ID: 4007420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution rate studies of cholesterol monohydrate in bile acid-lecithin solutions using the rotatingdisk method.
    Prakongpan S; Higuchi WI; Kwan KH; Molokhia AM
    J Pharm Sci; 1976 May; 65(5):685-9. PubMed ID: 932935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile.
    Corradini SG; Elisei W; Giovannelli L; Ripani C; Della Guardia P; Corsi A; Cantafora A; Capocaccia L; Ziparo V; Stipa V; Chirletti P; Caronna R; Lomanto D; Attili AF
    Gastroenterology; 2000 May; 118(5):912-20. PubMed ID: 10784590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary lipids alter ion transport during cholesterol gallstone formation.
    Abdou MS; Strichartz SD; Abedin MZ; Roslyn JJ
    J Surg Res; 1988 Jun; 44(6):672-9. PubMed ID: 3379944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol gallstone dissolution rate accelerators I: Exploratory investigations.
    Kwan KH; Higuchi WI; Molokhia AM; Hofmann AF
    J Pharm Sci; 1977 Aug; 66(8):1105-8. PubMed ID: 894495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating gallstone dissolution.
    Tao JC; Cussler EL; Evans DF
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3917-21. PubMed ID: 4530271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
    Grundy SM; Lan SP; Lachin J
    J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution kinetics of cholesterol in simulated bile I: Influence of bile acid type and concentration, bile acid-lecithin ration, and added electrolyte.
    Kwan KH; Higuchi WI; Molokhia AM; Hofmann AF
    J Pharm Sci; 1977 Aug; 66(8):1094-101. PubMed ID: 894494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent studies on the pathogenesis of cholelithiasis: the role of the gallbladder epithelium].
    Corradini SG; Liguori F
    Recenti Prog Med; 2001; 92(7-8):471-6. PubMed ID: 11475792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet.
    Amigo L; Quiñones V; Mardones P; Zanlungo S; Miquel JF; Nervi F; Rigotti A
    Gastroenterology; 2000 Apr; 118(4):772-9. PubMed ID: 10734029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol dissolution rate in micellar bile acid solutions: retarding effect of added lecithin.
    Higuchi WI; Prakongpan S; Surpuriya V; Young F
    Science; 1972 Nov; 178(4061):633-4. PubMed ID: 5086400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholesterol gallstone pathogenesis].
    Méndez N; Uribe M; Jessurun J; Uscanga L
    Rev Invest Clin; 1990 Jul; 42 Suppl():53-7. PubMed ID: 19256135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.